Publication | Open Access
Neuropathic Pain Phenotype Does Not Involve the NLRP3 Inflammasome and Its End Product Interleukin-1β in the Mice Spared Nerve Injury Model
47
Citations
54
References
2015
Year
Pain DisordersPain MedicineImmunologyImmune RegulationNeuropathic PainMolecular PainTissue DamageBasal Pain SensitivityNeuroinflammationInflammationPain SyndromeNlrp3 InflammasomeInflammasomePain ManagementNeurologyNeuroimmunologyMolecular SignalingHealth SciencesIl-1β ProductionInflammatory DiseasePain ResearchAnti-inflammatoryInflammation BiologyEnd Product Interleukin-1βPain MechanismMedicine
The NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome is one of the main sources of interleukin-1β (IL-1β) and is involved in several inflammatory-related pathologies. To date, its relationship with pain has not been studied in depth. The aim of our study was to elucidate the role of NLRP3 inflammasome and IL-1β production on neuropathic pain. Results showed that basal pain sensitivity is unaltered in NLRP3-/- mice as well as responses to formalin test. Spared nerve injury (SNI) surgery induced the development of mechanical allodynia and thermal hyperalgesia in a similar way in both genotypes and did not modify mRNA levels of the NLRP3 inflammasome components in the spinal cord. Intrathecal lipopolysaccharide (LPS) injection increases apoptosis-associated speck like protein (ASC), caspase-1 and IL-1β expression in both wildtype and NLRP3-/- mice. Those data suggest that NLRP3 is not involved in neuropathic pain and also that other sources of IL-1β are implicated in neuroinflammatory responses induced by LPS.
| Year | Citations | |
|---|---|---|
Page 1
Page 1